Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of…

Biotechnology

US, Carlsbad [HQ]

Summary
Fin. Reports
Financials
Leadership & Strategy
Government, Law & Regulation
Employees
More Analysis

Lobbying · US Senate · Influence

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Ionis Pharmaceuticals, Inc. to fulfill lobbying activities in the United States of America.

FY	Quarter	Lobby Expense [in mil. $]	Filing	Report Time
2024	3	2	LDA-2	Oct. 9, 2024, 6:59 p.m.